Pharmaceuticals - Jerusalem, Jerusalem District, Israel
ODE Pharma has developed an innovative and user-friendly biological medication that can potentially treat lung ailments and breathing difficulties, prevents deterioration of lung functions in people suffering from COVID-19, and enables them to recover quickly from the disease. The same pathological changes that compromise lung functions upon the COVID-19 infection also occur in other pulmonary diseases (e.g., Influenza, Asthma and CF) and thus can potentially be cured by our solution.ODE Pharma was born out of the collaboration between the Hebrew University of Jerusalem, Professor Shmuel Ben-Sasson (inventor and lead scientist) and Pollen Innovation Ltd, an Israeli-based investment firm focused on accelerating disruptive innovations and trends that enhance quality of life and contribute to a better and healthier world.
Horde
Apache
GoDaddy Hosting
Mobile Friendly